||3U01CA063736-05S1 Interpret this number
||Colorado State Dept/Pub Hlth & Environmt
||Breast Cancer Surveillance Research in Colorado
This proposal outlines the implementation and expansion of the Colorado
BC screening surveillance system to include all facilities throughout the
state that are involved in the provision of MM services to women.
Specifically, this proposal requests support for activities to track the
results of all MM completed for women in Colorado as well as conduct
diagnostic and treatment follow-up for all cases with screen-detected
abnormalities. This will include an estimated 300,000 MM and 45,000
women requiring diagnostic follow-up during the first year of the
project. Funding currently received from the CDC will be used to
continue the rescreening reminder component of CMAP as well as support
tracking and follow-up for women who receive subsidized BC screening
services from CPCP under the Colorado Women's Cancer Control Initiative.
The proposed expansion will be guided by the phased addition of MC
located in five specific regions in Colorado with the full expansion
completed by Project Year 05. Proposed surveillance activities will
include data collection for all completed MMs and characterization of
screening results for all women. In addition, diagnostic follow-up will
be conducted for all women with screen-detected abnormalities to
determine the nature and results of diagnostic evaluation. Further
follow-up will be conducted for women determined to have BC upon
completion of diagnostic follow-up to ensure that comprehensive data are
available concerning clinical characteristics of disease, treatment
protocols, morbidity and mortality. Biannual matches of the full
surveillance system database with all BC cases in the CCCR will be
completed in order to identify interval and non-screen-detected BCs.
These matches will also permit validation of data collected by the CPCP
surveillance system concerning screen-detected BCs. In addition, the
CPCP and CCCR will collaborate on the collection of pathobiology reports
for all biopsy cases reported to the surveillance system, including both
negative and positive biopsies. The CPCP will collaborate with a
national Consortium to define and accomplish standardized data collection
strategies and content as well as research priorities. In addition, the
CPCP will work with an Advisory Board and investigators from a number of
Colorado academic and health care to define and accomplish a BC research
agenda for Colorado that draws upon specific components of the proposed
screening surveillance system database.
None. See parent grant details.